Rating History for Seres Therapeutics (MCRB) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for MCRB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/24/2024 Tessa Romero Downgrade Underweight
(Neutral)		 N/A
(N/A)		 0.78
(7.21)		 824.36% Details